phenobarbital will reduce the extent or outcome of ramelteon by influencing hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Not known. phenobarbital will decrease the extent or effect of buprenorphine transdermal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep